Bridging therapy by azacitidine in a patient with atypical chronic myeloid leukemia, followed by human leukocyte antigen- haploidentical stem cell transplantation
Japanese Journal of Transplantation and Cellular Therapy · 2021
DOI: 10.7889/tct-21-003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Japanese Journal of Transplantation and Cellular Therapy, 2021. Verfasst von Miyo Goto und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Goto, M., Fukushima, N., Ito, M., Iida, S., Kawamura, Y., Ukai, S., Sagou, K., Kohno, A., & Ozeki, K. (2021). Bridging therapy by azacitidine in a patient with atypical chronic myeloid leukemia, followed by human leukocyte antigen- haploidentical stem cell transplantation. Japanese Journal of Transplantation and Cellular Therapy. https://doi.org/10.7889/tct-21-003
Vancouver
Goto M, Fukushima N, Ito M, Iida S, Kawamura Y, Ukai S, et al. Bridging therapy by azacitidine in a patient with atypical chronic myeloid leukemia, followed by human leukocyte antigen- haploidentical stem cell transplantation. Japanese Journal of Transplantation and Cellular Therapy. 2021. doi:10.7889/tct-21-003
BibTeX
@article{Goto2021,
author = {Goto, Miyo and Fukushima, Nobuaki and Ito, Makoto and Iida, Shiori and Kawamura, Yuma and Ukai, Shun and Sagou, Ken and Kohno, Akio and Ozeki, Kazutaka},
title = {Bridging therapy by azacitidine in a patient with atypical chronic myeloid leukemia, followed by human leukocyte antigen- haploidentical stem cell transplantation},
journal = {Japanese Journal of Transplantation and Cellular Therapy},
year = {2021},
doi = {10.7889/tct-21-003}
}
EUVIMED